STOCK TITAN

Roper director granted 84 restricted shares

Roper Technologies director Shellye L. Archambeau received 84 restricted shares that vest six months after the September 15, 2026 grant.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

ROPER TECHNOLOGIES INC (symbol: ROP) is the issuer of record for a Form 4 filing submitted to the SEC. ARCHAMBEAU SHELLYE L reported acquisition or exercise transactions in this Form 4 filing.

ROPER TECHNOLOGIES INC (ROP) reported that director Shellye L. Archambeau received a grant of 84 restricted shares of common stock on September 15, 2026. The shares were granted at $0.00 per share under the Director Compensation Plan and will vest on the six‑month anniversary of the grant date. Following this award, the director directly holds 9,561 shares of Roper Technologies common stock. No Rule 10b5‑1 trading plan is reported for this grant.

Positive

  • None.

Negative

  • None.
Insider ARCHAMBEAU SHELLYE L
Role Director
Type Security Shares Price Value
Grant/Award Common Stock F1 84 $0.00 $0.00
Holdings After Transaction: Common Stock — 9,561 shares (Direct)
Footnotes (1)
  1. F1. The securities reported are restricted shares granted to the reporting person pursuant to the Director Compensation Plan. The restricted shares vest on the 6-month anniversary of the grant date.
Restricted shares granted 84 shares Grant of restricted common stock to director on September 15, 2026
Grant price per share $0.00 per share Reported price for the restricted share grant to the director
Shares held after transaction 9,561 shares Total Roper Technologies common shares directly owned by the director after the grant
Grant date September 15, 2026 Date of restricted share grant under the Director Compensation Plan
Vesting period 6 months Restricted shares vest on the six‑month anniversary of the grant date
restricted shares financial
"The securities reported are restricted shares granted to the reporting person"
Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.
Director Compensation Plan financial
"restricted shares granted to the reporting person pursuant to the Director Compensation Plan"
vest financial
"The restricted shares vest on the 6-month anniversary of the grant date"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ROP disclose for Shellye L. Archambeau?

ROP disclosed that director Shellye L. Archambeau received a grant of 84 restricted shares of common stock on September 15, 2026 as a compensation award under the Director Compensation Plan.

At what price were the 84 ROP shares granted to the director?

The 84 ROP shares were granted at a reported price of $0.00 per share, reflecting that they are restricted shares granted as director compensation rather than purchased in the open market.

When do the newly granted ROP restricted shares vest?

The filing states that the restricted shares vest on the six‑month anniversary of the September 15, 2026 grant date, meaning vesting occurs six months after that grant date under the Director Compensation Plan.

How many ROP shares does the director hold after this grant?

After the grant, director Shellye L. Archambeau directly holds 9,561 shares of Roper Technologies common stock, as reported as the total shares beneficially owned following the transaction.

Was a Rule 10b5-1 trading plan involved in this ROP Form 4 transaction?

No. The Form 4 indicates the Rule 10b5‑1 checkbox is not checked, and the footnotes do not describe any trading plan, so no Rule 10b5‑1 plan is reported for this grant.

What is the nature of the ROP shares granted to the director?

The filing footnote explains that the securities are restricted shares granted to the reporting person pursuant to the Director Compensation Plan, with vesting on the six‑month anniversary of the grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ARCHAMBEAU SHELLYE L

(Last)(First)(Middle)
C/O ROPER TECHNOLOGIES, INC.
6496 UNIVERSITY PARKWAY

(Street)
SARASOTA FLORIDA 34240

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ROPER TECHNOLOGIES INC [ ROP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/15/2026A84(1)A$09,561D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The securities reported are restricted shares granted to the reporting person pursuant to the Director Compensation Plan. The restricted shares vest on the 6-month anniversary of the grant date.
/s/ John K. Stipancich, Attorney-In-Fact09/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading